Targeted deep sequencing of urothelial bladder cancers and associated urinary DNA: a 23-gene panel with utility for non-invasive diagnosis and risk stratification.

BJU Int · 2019 · PMC6772022 · PMID 31077629

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

approached significanceP = 0.06so close (0.05 < p ≤ 0.1)

We also analysed the influence of SMs on time to progression and disease‐specific survival in patients with high‐risk NMIBC; the association between FGFR3 mutations and longer time to progression approached significance (HR 0.35, 95% CI 0.12–1.05; P = 0.06).

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.